264 related articles for article (PubMed ID: 36215167)
41. Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case report.
Taylor DG; Ilyas A; Mehta GU; Chen CJ; Schiff D; Oldfield EH; Asthagiri AR
J Clin Neurosci; 2018 Apr; 50():154-156. PubMed ID: 29396065
[TBL] [Abstract][Full Text] [Related]
42. Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina.
Wang H; Shepard MJ; Zhang C; Dong L; Walker D; Guedez L; Park S; Wang Y; Chen S; Pang Y; Zhang Q; Gao C; Wong WT; Wiley H; Pacak K; Chew EY; Zhuang Z; Chan CC
Cancer Res; 2018 Mar; 78(5):1266-1274. PubMed ID: 29301791
[TBL] [Abstract][Full Text] [Related]
43. [Genetics and angiogenesis: the example of von Hippel-Lindau disease].
Richard S; Ladroue C; Gad S; Giraud S; Gardie B;
Bull Cancer; 2007 Jul; 94 Spec No():S170-9. PubMed ID: 17846002
[TBL] [Abstract][Full Text] [Related]
44. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.
Richard S; David P; Marsot-Dupuch K; Giraud S; Béroud C; Resche F
Neurosurg Rev; 2000 Mar; 23(1):1-22; discussion 23-4. PubMed ID: 10809480
[TBL] [Abstract][Full Text] [Related]
45. The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing.
Kaelin WG
Cold Spring Harb Symp Quant Biol; 2005; 70():159-66. PubMed ID: 16869749
[TBL] [Abstract][Full Text] [Related]
46. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
[TBL] [Abstract][Full Text] [Related]
47. Comprehensive characterization and building of National Registry of von Hippel-Lindau disease in Brazil.
Dallagnol TN; Da Cás E; Junior OR; Casali-da-Rocha JC
Mol Genet Genomic Med; 2023 Apr; 11(4):e2136. PubMed ID: 36625343
[TBL] [Abstract][Full Text] [Related]
48. Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family.
Yuan P; Sun Q; Liang H; Wang W; Li L; Wang Y; Deng H; Lai L; Chen X; Zhou X
Cancer Biol Ther; 2016 Jun; 17(6):599-603. PubMed ID: 27057652
[TBL] [Abstract][Full Text] [Related]
49. [Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer].
Moch H
Pathologe; 2008 Nov; 29 Suppl 2():149-52. PubMed ID: 18751708
[TBL] [Abstract][Full Text] [Related]
50. VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease.
Mathó C; Sansó G; Diez B; Barontini M; Pennisi PA
Genet Test Mol Biomarkers; 2016 Dec; 20(12):771-776. PubMed ID: 27617348
[TBL] [Abstract][Full Text] [Related]
51. Developmentally Arrested Basket/Stellate Cells in Postnatal Human Brain as Potential Tumor Cells of Origin for Cerebellar Hemangioblastoma in von Hippel-Lindau Patients.
Shively SB; Edwards NA; MacDonald TJ; Johnson KR; Diaz-Rodriguez NM; Merrill MJ; Vortmeyer AO
J Neuropathol Exp Neurol; 2022 Oct; 81(11):885-899. PubMed ID: 35980299
[TBL] [Abstract][Full Text] [Related]
52. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
53. A novel missense mutation (N78D) in a family with von Hippel-Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts.
Cingoz S; van der Luijt RB; Kurt E; Apaydin M; Akkol I; Ozgen MH
Fam Cancer; 2013 Mar; 12(1):111-7. PubMed ID: 23224817
[TBL] [Abstract][Full Text] [Related]
54. Von Hippel-Lindau disease.
Chittiboina P; Lonser RR
Handb Clin Neurol; 2015; 132():139-56. PubMed ID: 26564077
[TBL] [Abstract][Full Text] [Related]
55. Case of parotid mucoepidermoid carcinoma: Expanding the spectrum of von Hippel-Lindau-related neoplasms.
Berger MH; Kerr DA; Rangel Filho AE; Sargi ZB
Head Neck; 2017 Mar; 39(3):E51-E54. PubMed ID: 28006088
[TBL] [Abstract][Full Text] [Related]
56. von Hippel-Lindau disease: a clinical and scientific review.
Maher ER; Neumann HP; Richard S
Eur J Hum Genet; 2011 Jun; 19(6):617-23. PubMed ID: 21386872
[TBL] [Abstract][Full Text] [Related]
57. [Von Hippel-Lindau syndrome - a case report].
Figlus M; Kaczorowska B; Jaskólski DJ; Kępczyński Ł
Pol Merkur Lekarski; 2018 May; 44(263):248-252. PubMed ID: 29813043
[TBL] [Abstract][Full Text] [Related]
58. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
[TBL] [Abstract][Full Text] [Related]
59. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
[TBL] [Abstract][Full Text] [Related]
60. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
Stratmann R; Krieg M; Haas R; Plate KH
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
